ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,620Medicare Part D Prescriptions Filled, Including Refills

Rank: 121 out of 3593

$839K Total Retail Price of All Prescriptions

Rank: 203 out of 3593

901 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 901 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 17,818 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LOVASTATIN 1,118 1,014 1 20
LEVOTHYROXINE SODIUM 968 837 2 4
AMLODIPINE BESYLATE 962 837 3 3
LISINOPRIL 768 685 4 2
OMEPRAZOLE 755 669 5 5
PRAVASTATIN SODIUM 580 510 6 13
ALENDRONATE SODIUM 579 571 7 22
METFORMIN HCL 529 380 8 6
METOPROLOL TARTRATE 496 448 9 8
HYDROCHLOROTHIAZIDE 492 434 10 10
LOSARTAN POTASSIUM 491 440 11 14
SIMVASTATIN 430 343 12 1
FUROSEMIDE 421 363 13 9
HYDROCODONE-ACETAMINOPHEN 403 349 S3 14 7
POTASSIUM CHLORIDE 308 279 15 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 298 264 16 26
WARFARIN SODIUM 282 272 17 18
GLIPIZIDE 266 230 18 40
METOPROLOL SUCCINATE 265 240 19 19
ZOLPIDEM TARTRATE 241 178 20 12
ATENOLOL 237 228 21 11
GABAPENTIN 209 173 22 16
DOXAZOSIN MESYLATE 203 196 23 63
DIGOXIN 178 166 24 58
ENALAPRIL MALEATE 177 146 25 38
PAROXETINE HCL 172 158 26 62
SERTRALINE HCL 171 140 27 28
CITALOPRAM HBR 166 147 28 25
NAMENDA 164 161 29 50
GLYBURIDE 160 157 R 30 55
PANTOPRAZOLE SODIUM 155 132 31 45
PROAIR HFA 153 128 32 54
CARVEDILOL 142 125 33 23
ADVAIR DISKUS 138 110 34 47
GEMFIBROZIL 138 99 34 88
CRESTOR 136 117 36 21
DONEPEZIL HCL 128 127 37 31
RANITIDINE HCL 126 96 38 27
PREDNISONE 125 119 39 49
DILTIAZEM ER 120 113 40 194
CLONIDINE HCL 117 93 41 41
LANTUS 117 93 41 57
DIOVAN 117 117 41 46
DICLOFENAC SODIUM 104 91 44 74
ATORVASTATIN CALCIUM 103 83 45 15
DILTIAZEM 24HR CD 102 102 46 173
TRAMADOL HCL 101 80 47 17
FLUTICASONE PROPIONATE 100 94 48 32
FLUOXETINE HCL 96 79 49 60
CLOPIDOGREL 95 78 50 30
PENTOXIFYLLINE 94 92 51 149
AZITHROMYCIN 94 82 51 34
INSULIN SYRINGE 94 76 51 91
LANTUS SOLOSTAR 90 65 54 122
ALLOPURINOL 90 85 54 35
SYNTHROID 89 82 56 51
ISOSORBIDE MONONITRATE ER 89 89 56 61
VERAPAMIL ER 87 87 58 99
METHYLPREDNISOLONE 85 75 59 103
CYMBALTA 84 54 60 73
KLOR-CON 10 84 79 60 114
MELOXICAM 81 60 62 29
TRAZODONE HCL 79 66 63 53
DILTIAZEM 24HR ER 78 76 64 177
AMITRIPTYLINE HCL 77 50 R 65 90
PLAVIX 72 63 66 42
KLOR-CON M20 71 58 67 139
JANUVIA 70 49 68 81
VENTOLIN HFA 70 60 68 80
CARTIA XT 69 69 70 299
OXYBUTYNIN CHLORIDE 67 64 71 104
BUPROPION HCL SR 64 46 72 207
GLYBURIDE-METFORMIN HCL 63 63 R 73 95
CIPROFLOXACIN HCL 63 51 73 52
TRIAMTERENE-HCTZ 60 41 75 66
NEXIUM 60 32 75 36
PEN NEEDLE 58 48 77 188
CILOSTAZOL 57 57 78 163
CEPHALEXIN 56 44 79 150
GLIMEPIRIDE 56 45 79 44
IBUPROFEN 54 49 81 43
QUETIAPINE FUMARATE 54 54 81 89
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 45 83 102
TERAZOSIN HCL 52 52 83 115
QVAR 51 34 85 293
COMBIVENT 51 39 85 161
SPIRONOLACTONE 50 38 87 86
WELCHOL 50 48 87 285
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.